These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34145585)

  • 1. Chemical diversity and cellular effects of antifungal cyclic lipopeptides from cyanobacteria.
    Fewer DP; Jokela J; Heinilä L; Aesoy R; Sivonen K; Galica T; Hrouzek P; Herfindal L
    Physiol Plant; 2021 Oct; 173(2):639-650. PubMed ID: 34145585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Biosynthetic Starter Units Enhance the Structural Diversity of Cyanobacterial Lipopeptides.
    Mareš J; Hájek J; Urajová P; Kust A; Jokela J; Saurav K; Galica T; Čapková K; Mattila A; Haapaniemi E; Permi P; Mysterud I; Skulberg OM; Karlsen J; Fewer DP; Sivonen K; Tønnesen HH; Hrouzek P
    Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30504214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway.
    Vestola J; Shishido TK; Jokela J; Fewer DP; Aitio O; Permi P; Wahlsten M; Wang H; Rouhiainen L; Sivonen K
    Proc Natl Acad Sci U S A; 2014 May; 111(18):E1909-17. PubMed ID: 24742428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity improved by coproduction of cyclodextrins and anabaenolysins in Cyanobacteria.
    Shishido TK; Jokela J; Kolehmainen CT; Fewer DP; Wahlsten M; Wang H; Rouhiainen L; Rizzi E; De Bellis G; Permi P; Sivonen K
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13669-74. PubMed ID: 26474830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interaction of the antifungal and cytotoxic cyclic glycolipopeptide hassallidin with sterol-containing lipid membranes.
    Humisto A; Jokela J; Teigen K; Wahlsten M; Permi P; Sivonen K; Herfindal L
    Biochim Biophys Acta Biomembr; 2019 Aug; 1861(8):1510-1521. PubMed ID: 31226245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of cyclic lipopeptide puwainaphycins from cyanobacteria by countercurrent chromatography combined with polymeric resins and HPLC.
    Cheel J; Urajová P; Hájek J; Hrouzek P; Kuzma M; Bouju E; Faure K; Kopecký J
    Anal Bioanal Chem; 2017 Feb; 409(4):917-930. PubMed ID: 27904937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure and biosynthesis of heinamides A1-A3 and B1-B5, antifungal members of the laxaphycin lipopeptide family.
    Heinilä LMP; Fewer DP; Jokela JK; Wahlsten M; Ouyang X; Permi P; Jortikka A; Sivonen K
    Org Biomol Chem; 2021 Jun; 19(25):5577-5588. PubMed ID: 34085692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabaenolysins, novel cytolytic lipopeptides from benthic Anabaena cyanobacteria.
    Jokela J; Oftedal L; Herfindal L; Permi P; Wahlsten M; Døskeland SO; Sivonen K
    PLoS One; 2012; 7(7):e41222. PubMed ID: 22829929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal compounds from cyanobacteria.
    Shishido TK; Humisto A; Jokela J; Liu L; Wahlsten M; Tamrakar A; Fewer DP; Permi P; Andreote AP; Fiore MF; Sivonen K
    Mar Drugs; 2015 Apr; 13(4):2124-40. PubMed ID: 25871291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearranged Biosynthetic Gene Cluster and Synthesis of Hassallidin E in Planktothrix serta PCC 8927.
    Pancrace C; Jokela J; Sassoon N; Ganneau C; Desnos-Ollivier M; Wahlsten M; Humisto A; Calteau A; Bay S; Fewer DP; Sivonen K; Gugger M
    ACS Chem Biol; 2017 Jul; 12(7):1796-1804. PubMed ID: 28489343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hassallidin B--second antifungal member of the Hassallidin family.
    Neuhof T; Schmieder P; Seibold M; Preussel K; von Döhren H
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4220-2. PubMed ID: 16777415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-synthetic puwainaphycin/minutissamide cyclic lipopeptides with improved antifungal activity and limited cytotoxicity.
    Hájek J; Bieringer S; Voráčová K; Macho M; Saurav K; Delawská K; Divoká P; Fišer R; Mikušová G; Cheel J; Fewer DP; Vu DL; Paichlová J; Riepl H; Hrouzek P
    RSC Adv; 2021 Sep; 11(49):30873-30886. PubMed ID: 35498921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and Functional Insights into Iturin W, a Novel Lipopeptide Produced by the Deep-Sea Bacterium
    Zhou S; Liu G; Zheng R; Sun C; Wu S
    Appl Environ Microbiol; 2020 Oct; 86(21):. PubMed ID: 32859591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanobacteria-derived peptide antibiotics discovered since 2000.
    Xue Y; Zhao P; Quan C; Zhao Z; Gao W; Li J; Zu X; Fu D; Feng S; Bai X; Zuo Y; Li P
    Peptides; 2018 Sep; 107():17-24. PubMed ID: 30077717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared PKS Module in Biosynthesis of Synergistic Laxaphycins.
    Heinilä LMP; Fewer DP; Jokela JK; Wahlsten M; Jortikka A; Sivonen K
    Front Microbiol; 2020; 11():578878. PubMed ID: 33042096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new A- and B-type laxaphycins with synergistic anticancer activity.
    Cai W; Matthew S; Chen QY; Paul VJ; Luesch H
    Bioorg Med Chem; 2018 May; 26(9):2310-2319. PubMed ID: 29606488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of HPCCC Combined with Polymeric Resins and HPLC for the Separation of Cyclic Lipopeptides Muscotoxins A⁻C and Their Antimicrobial Activity.
    Cheel J; Hájek J; Kuzma M; Saurav K; Smýkalová I; Ondráčková E; Urajová P; Vu DL; Faure K; Kopecký J; Hrouzek P
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30332796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Production of Two Anti-
    Ramchandran R; Ramesh S; A A; Thakur R; Chakrabarti A; Roy U
    Curr Pharm Biotechnol; 2020; 21(5):438-450. PubMed ID: 31804165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholdines from Burkholderia ambifaria: antifungal agents and possible virulence factors.
    Lin Z; Falkinham JO; Tawfik KA; Jeffs P; Bray B; Dubay G; Cox JE; Schmidt EW
    J Nat Prod; 2012 Sep; 75(9):1518-23. PubMed ID: 22988812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Lipid Composition, Physicochemical Interactions, and Membrane Mechanics in the Molecular Actions of Microbial Cyclic Lipopeptides.
    Balleza D; Alessandrini A; Beltrán García MJ
    J Membr Biol; 2019 Jun; 252(2-3):131-157. PubMed ID: 31098678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.